IP Library Granted Patent US 7,767,830
Granted Patent B2
US 7,767,830 · App. 11/690,361 · Granted Aug 3, 2010

Aminocyclohexyl ether compounds and uses thereof

Assignee: Cardiome Pharma Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,830
App. No.
11/690,361
Granted
Aug 3, 2010
Kind
B2
Abstract

Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.

Claims (65)

1. A method of making compound (5RRR) or compound (5SSR):

wherein the method comprises the steps of:

a) reacting

 with (Boc) 2 O under suitable conditions to form compound (1R):

b) reacting compound (1R) with benzyl bromide under suitable conditions to form compound (2R):

c) hydrolyzing compound (2R) under suitable conditions to form compound (3R):

d) reacting compound (3R) with

 under suitable conditions to form compound (4R):

e) reacting compound (4R) with

 under suitable conditions to form compound (5R);

f) resolving compound (5R) under suitable conditions to form compound (5RRR) and compound (5SSR).

2. The method of claim 1 further comprising the step of:

reacting compound (5RRR) with acetyl chloride under suitable conditions to form compound (17):

3. A method of making compound (5R):

wherein the method comprises the steps of:

a) reacting

 with (Boc) 2 O under suitable conditions to form compound (1R):

b) reacting compound (1R) with benzyl bromide under suitable conditions to form compound (2R):

c) hydrolyzing compound (2R) under suitable conditions to form compound (3R):

d) reacting compound (3R) with

 under suitable conditions to form compound (4R):

 and

e) reacting compound (4R) with

 under suitable conditions to form compound (5R).

4. The method of claim 3 further comprising the step of:

hydrolyzing compound (5R) under suitable conditions to form compound (4):

5. The method of claim 3 further comprising the step of:

reacting compound (5R) with hydrogen chloride under suitable conditions to form compound (12):

6. A method of making compound (1):

wherein the method comprises the step of hydrogenolyzing compound (5RRR):

under suitable conditions to form compound (1).

7. The method of claim 6 further comprising, prior to the hydrogenolyzing step, the step of:

resolving compound (5R):

under suitable conditions to form compound (5RRR).

8. The method of claim 7 further comprising, prior to the resolving step, the step of:

reacting compound (4R):

with

 under suitable conditions to form compound (5R).

9. The method of claim 8 further comprising, prior to the reacting step, the step of:

reacting compound (3R):

with

 under suitable conditions to form compound (4R).

10. The method of claim 9 further comprising, prior to the reaction of compound (3R) with

 the step of hydrolyzing compound (2R):

under suitable conditions to form compound (3R).

11. A method of making compound (2):

wherein the method comprises the step of hydrogenolyzing compound (5SSR):

under suitable conditions to form compound (2).

12. The method of claim 11 further comprising, prior to the hydrogenolyzing step, the step of:

resolving compound (5R):

under suitable conditions to form compound (5SSR).

13. The method of claim 12 further comprising, prior to the resolving step, the step of:

reacting compound (4R):

with

 under suitable conditions to form compound (5R).

14. The method of claim 13 further comprising, prior to the reacting step, the step of:

reacting compound (3R):

with

 under suitable conditions to form compound (4R).

15. The method of claim 14 further comprising, prior to the reaction of compound (3R) with

 the step of hydrolyzing compound (2R):

under suitable conditions to form compound (3R).

16. The compound (5RRR):

17. The compound (5SSR):

18. The compound (5R):

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2018
From: CARDIOME PHARMA CORP.
To: CORREVIO CANADA CORP.
Reel/Frame 046831/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2018
From: CORREVIO CANADA CORP.
To: CORREVIO INTERNATIONAL SÀRL
Reel/Frame 046831/0227 →
RELEASE OF SECURITY INTEREST Recorded Jun 20, 2016
From: MIDCAP FINANCIAL TRUST
To: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
Reel/Frame 038961/0202 →
SECURITY INTEREST Recorded Jul 24, 2014
From: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
To: MIDCAP FUNDING V, LLC
Reel/Frame 033407/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2007
From: JUNG, GRACE; PLOUVIER, BERTRAND M. C.; LIU, YUZHONG; ZHU, JEFF JIQUN; SHENG, TAO; BARRETT, ANTHONY G. M.; CHOI, LEWIS SIU LEUNG; CHOU, DOUG TA HUNG
To: CARDIOME PHARMA CORP.
Reel/Frame 019518/0907 →
Continuity (9)
Continuation 1055536400
Provisional Application 6046715900 · May 2, 2003
Provisional Application 6047608300 · Jun 4, 2003
Provisional Application 6047588400 · Jun 5, 2003
Provisional Application 6047591200 · Jun 5, 2003
Provisional Application 6047644700 · Jun 5, 2003
Provisional Application 6048965900 · Jul 23, 2003
Provisional Application 6049339200 · Aug 7, 2003
Related Publication 20070254945A1 · Nov 1, 2007